Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.

D D Bikle; B P Halloran; E Gee; E Ryzen; J G Haddad

doi:10.1172/JCI112636

Find articles by Bikle, D. in: PubMed | Google Scholar

Find articles by Halloran, B. in: PubMed | Google Scholar

Find articles by Gee, E. in: PubMed | Google Scholar

Find articles by Ryzen, E. in: PubMed | Google Scholar

Find articles by Haddad, J. in: PubMed | Google Scholar

Published in Volume 78, Issue 3 on September 1, 1986
J Clin Invest. 1986;78(3):748–752. https://doi.org/10.1172/JCI112636.
© 1986 The American Society for Clinical Investigation

Published September 1, 1986 - Version history

We determined the free fraction of 25-dihydroxyvitamin D (25OHD) in the serum of subjects with clinical evidence of liver disease and correlated these measurements to the levels of vitamin D binding protein and albumin. These subjects when compared to normal individuals had lower total 25OHD levels, higher percent free 25OHD levels, but equivalent free 25OHD levels. These subjects also had reduced vitamin D binding protein and albumin concentrations. The total concentration of 25OHD correlated positively with both vitamin D binding protein and albumin, whereas the percent free 25OHD correlated negatively with vitamin D binding protein and albumin. The free 25OHD levels did not correlate with either vitamin D binding protein or albumin. We conclude that total vitamin D metabolite measurements may be misleading in the evaluation of the vitamin D status of patients with liver disease, and recommend that free 25OHD levels also be determined before making a diagnosis of vitamin D deficiency.

Click on an image below to see the page. View PDF of the complete article